Overweight and obesity in the context of heart failure: implications for practice and future research

Lorraine S Evangelista1, Pamela S Miller

  • 1School of Nursing, University of California-Los Angeles, 700 Tiverton, Los Angeles, CA 90095-6918, USA. levangel@ucla.edu

Insights

Overweight and obesity's impact on heart failure (HF) is complex, with studies showing both risks and benefits to survival. Lifestyle modifications are key for managing HF in affected individuals.

Area of Science:

  • Cardiology
  • Public Health
  • Obesity Medicine

Background:

  • Heart failure (HF) is a significant cardiovascular disease with high hospitalization rates.
  • The rising prevalence of overweight and obesity presents a growing public health challenge.
  • Overweight and obesity are traditionally linked to increased cardiovascular morbidity and mortality.

Purpose of the Study:

  • To review the dual effects of overweight and obesity on heart failure outcomes.
  • To explore the implications for future research directions in HF.
  • To provide practice recommendations for lifestyle modification in HF patients.

Main Methods:

  • Literature review of studies examining overweight/obesity and HF survival.
  • Analysis of data on the association between body mass and HF prognosis.
  • Synthesis of evidence regarding lifestyle interventions for HF management.

Main Results:

  • Evidence suggests overweight and obesity may have protective effects on survival post-heart failure onset.
  • Contrasting data exists, highlighting a complex relationship between body mass and HF outcomes.
  • Lifestyle modifications including diet, exercise, and cognitive-behavioral therapy are recommended.

Conclusions:

  • The relationship between overweight/obesity and heart failure is multifaceted, requiring further investigation.
  • Clinical practice should consider the nuanced effects of body weight on HF prognosis.
  • Personalized lifestyle interventions are crucial for optimizing heart failure care.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
182
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
381
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
220
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
638
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
639
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K